Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.68    0.03 (0.65%)
Bid:
4.61
Ask:
4.695
Spread: 0.085 (1.844%)
Market Cap: £224.62m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

NEW FACEAPI PRODUCT RELEASE

26 Aug 2008 08:33

RNS Number : 9816B
Seeing Machines Limited
26 August 2008
 



26 August 2008

Seeing Machines Limited

("Seeing Machines" or the "Company")

SEEING MACHINES ANNOUNCES NEW FACEAPI PRODUCT RELEASE

Seeing Machines (AIM: SEE), a leading developer of advanced computer based imaging software systems, yesterday released a new version of its faceAPI product, a face tracking toolkit for Original Equipment Manufacturers (OEM's) and application developers that turns a web camera into a 3D face tracking device.  The product was released at NVISION 08 NVIDIA's visual computing conference held in San Jose California this week.

"The new release of the faceAPI boasts a large number of new features and improvements. We have delivered on requests from our partners and customers, and then some" said Nick Langdale-Smith, Director of Sales and Marketing for Seeing Machines. "One of the major additions is the unique ability to track lip and eyebrow movements, enabling games and virtual worlds to read a user's facial expression, as well as head orientation and movement". 

Dr Nick Cerneaz, CEO of Seeing Machines commenting on the release said "This release of the faceAPI product is a very important part of our long term strategy. We expect this version of the faceAPI to be the springboard for the commercial success of this product".

Further information about Seeing Machines and faceAPI can be obtained from the Company web site: www.seeingmachines.com.

--- ENDS ---

Enquiries:

Seeing Machines Limited

Grant Thornton UK LLP

Parkgreen Communications

Nick Cerneaz, CEO

Fiona Owen

Paul McManusHelen Westaway

+61 (0) 2 6125 6501

+44 (0) 20 7383 5100

+44 (0) 20 7851 7480

www.seeingmachines.com

  Notes to editors:

About Seeing Machines

Seeing Machines is an award winning Technology Company which focuses on vision based human machine interfaces. Formed in 2000 in CanberraAustralia, Seeing Machines purpose is to commercialize its computer-vision across a range of industries and applications. 

Seeing Machines delivers advanced computer vision solutions for researchers and developers in human factors, transportation safety, entertainment, computer human interaction, robotics and medical research. 

Seeing Machines computer vision systems are able to measure the orientation and position of a human head, estimate eye-gaze direction, detect eye blinks and track other facial features. This functionality is achieved entirely though visual means, using video cameras connected to advanced image processing software, with no attachments required on the subject. The faceAPI® product encapsulates the core of Seeing Machines computer-vision algorithms into a package designed for licensing to OEM's and third-parties.

The flagship product faceLAB® provides an automated and contact-free gaze and head tracking technology, it solves the problem of observing human behaviour naturally, non-intrusively and with a high degree of accuracy and usability. Building on these unique face tracking and pupil measurement and monitoring capabilities, the TrueField Analyzer® is new medical device to assist clinicians detect and manage eye diseases such as glaucoma.

The TrueField Analyzer® offers a new objective method to help doctors diagnose and manage a range of eye diseases including glaucoma, age related macular degeneration and diabetic retinopathy. Glaucoma affects about 2-3% of the population over 40 years of age and is a leading source of blindness. Unlike most other devices available to the clinician the TrueField Analyzer is a completely objective test and it is quick and easy for patients and technicians alike. The device measures both eyes concurrently and due to the reliability that arises from the objective nature of the test, it has the potential to become a new standard in the measurement of visual field defects and thus in the diagnosis and management of disease such as glaucoma.

The Driver State Sensor is driver monitoring software targeted at the detection of fatigue and distraction in drivers and operators. The DSS detects drowsiness (fatigue) or that the driver is distracted and their attention has been diverted from the road, alarms are raised to alert the driver to these events. In larger deployments, such as in fleet and mining equipment operations, the data is available in both real-time and off-line modes for fleet management, driver training and awareness programs

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PRLGRGDIDXDGGIL
Date   Source Headline
28th Apr 20217:09 amRNSDMS central to improved safety on US roads
26th Apr 20217:00 amRNSDMS award brings OEM customer count to seven
31st Mar 20217:00 amRNSHalf-year results and financial report
22nd Mar 20217:00 amRNSIssue of shares and total voting rights
19th Mar 20217:16 amRNSNotice of Results and Investor Presentation
8th Feb 20217:00 amRNSSEE DMS Available in 2021 Cadillac Escalade
3rd Feb 20217:30 amRNSHolding(s) in Company
1st Feb 20217:00 amRNSHalf year trading update
27th Jan 20217:00 amRNSQualcomm and Seeing Machines collaboration
13th Jan 20214:41 pmRNSSecond Price Monitoring Extn
13th Jan 20214:35 pmRNSPrice Monitoring Extension
13th Jan 20218:48 amRNSHolding(s) in Company
6th Jan 20217:00 amRNSLicense Agreement with OmniVision Technologies
22nd Dec 20207:00 amRNSFleet Update
30th Nov 20209:19 amRNS2020 AGM Results and Board Changes
25th Nov 202011:50 amRNSDirector/PDMR Shareholding
23rd Nov 202010:00 amRNSShare Transfer & Issue of Performance Rights
5th Nov 20208:02 amRNSNotice of AGM
2nd Nov 202011:43 amRNSHolding(s) in Company
2nd Nov 20207:00 amRNSYear End Results
30th Oct 20209:19 amRNSHolding(s) in Company
30th Oct 20207:00 amRNSWebcast Presentation - Year End Results
29th Oct 202011:39 amRNSHolding(s) in Company
29th Oct 20207:00 amRNSHolding(s) in Company
23rd Oct 20207:00 amRNSIssue of Shares & Total Voting Rights
21st Oct 20207:00 amRNSSEE signs MOU with L3Harris Technologies
12th Oct 20207:00 amRNSSEE extends leading DMS to Occupant Monitoring
16th Sep 20207:15 amRNS5 billion kilometres of Guardian driving data
14th Sep 20207:00 amRNSLaunch of DMS Kit on Qualcomm Snapdragon Platform
8th Sep 20209:05 amRNSSecond Price Monitoring Extn
8th Sep 20209:00 amRNSPrice Monitoring Extension
8th Sep 20207:00 amRNSSEE signs MOU with leading Semiconductor Company
2nd Sep 20209:00 amRNSNext Gen Embedded Product Strategy for Auto DMS
14th Aug 202010:55 amRNSShare purchase by PCA of non-executive director
3rd Aug 20207:00 amRNSFY20 Trading Update
7th Jul 20207:00 amRNSUS set to mandate DMS from 2024
19th May 20207:00 amRNSBusiness restructure and Covid measures
14th May 20207:00 amRNSBoard Changes
6th May 202011:05 amRNSSecond Price Monitoring Extn
6th May 202011:00 amRNSPrice Monitoring Extension
5th May 20204:41 pmRNSSecond Price Monitoring Extn
5th May 20204:35 pmRNSPrice Monitoring Extension
14th Apr 20201:53 pmRNSHolding(s) in Company
9th Apr 20207:00 amRNSDirector/PDMR Shareholding
6th Apr 20204:40 pmRNSSecond Price Monitoring Extn
6th Apr 20204:35 pmRNSPrice Monitoring Extension
2nd Apr 20202:06 pmRNSSecond Price Monitoring Extn
2nd Apr 20202:00 pmRNSPrice Monitoring Extension
2nd Apr 202011:00 amRNSPrice Monitoring Extension
1st Apr 20204:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.